{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:15:05Z","timestamp":1790727305778,"version":"4.1.0"},"reference-count":75,"publisher":"American Dairy Science Association","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004687","name":"Universidad de Murcia","doi-asserted-by":"publisher","award":["5622019"],"award-info":[{"award-number":["5622019"]}],"id":[{"id":"10.13039\/501100004687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalofdairyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dairy Science"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.3168\/jds.2024-25194","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:09:20Z","timestamp":1742911760000},"page":"5218-5232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetic\/pharmacodynamic modeling in plasma and milk and Monte Carlo simulations of marbofloxacin against Staphylococcus aureus and Mycoplasma agalactiae in lactating sheep"],"prefix":"10.3168","volume":"108","author":[{"given":"J.M.","family":"Serrano-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fern\u00e1ndez-Var\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mu\u00f1oz-Rasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mor\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"D\u00edaz-Villamar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"de la Fe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"C\u00e1rceles-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"C\u00e1rceles-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1747","reference":[{"key":"10.3168\/jds.2024-25194_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/aem.43.4.958-960.1982","article-title":"Simple method for quantitation of viable mycoplasmas","volume":"43","author":"Albers","year":"1982","journal-title":"Appl. Environ. Microbiol."},{"key":"10.3168\/jds.2024-25194_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2885.2002.00399.x","article-title":"Pharmacokinetics and pharmacokinetic\/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate","volume":"25","author":"Aliabadi","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s11250-019-01980-5","article-title":"The effects of Mannheimia haemolytica and albendazole on marbofloxacin pharmacokinetics in lambs","volume":"51","author":"Altan","year":"2019","journal-title":"Trop. Anim. Health Prod."},{"key":"10.3168\/jds.2024-25194_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jiac.2015.02.001","article-title":"Applications of the pharmacokinetic\/pharmacodynamic (PK\/PD) analysis of antimicrobial agents","volume":"21","author":"As\u00edn-Prieto","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"10.3168\/jds.2024-25194_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00003088-199018020-00005","article-title":"Prediction of drug distribution into human milk from physicochemical characteristics","volume":"18","author":"Atkinson","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.3168\/jds.2024-25194_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jvp.12473","article-title":"Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics","volume":"41","author":"Bon","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/evj.13385","article-title":"Determination of the pharmacokinetic-pharmacodynamic cut-off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing","volume":"53","author":"Bousquet-M\u00e9lou","year":"2021","journal-title":"Equine Vet. J."},{"key":"10.3168\/jds.2024-25194_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.3168\/jds.2024-25194_bib9","series-title":"Comparative Pharmacokinetics: Principles, Techniques and Applications","first-page":"296","article-title":"Study design and data analysis","author":"Chittenden","year":"2011"},{"key":"10.3168\/jds.2024-25194_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac626","article-title":"Optimizing clinical outcomes through rational dosing strategies: Roles of pharmacokinetic\/pharmacodynamic modeling tools","volume":"9","author":"Chua","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"10.3168\/jds.2024-25194_bib11","series-title":"Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals","author":"CLSI (Clinical and Laboratory Standards Institute)","year":"2017"},{"key":"10.3168\/jds.2024-25194_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.smallrumres.2006.09.011","article-title":"Mastitis in small ruminants","volume":"68","author":"Contreras","year":"2007","journal-title":"Small Rumin. Res."},{"key":"10.3168\/jds.2024-25194_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/jvp.12849","article-title":"Effect of supportive therapy on the pharmacokinetics of intravenous marbofloxacin in endotoxemic sheep","volume":"43","author":"Coskun","year":"2020","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.phrs.2018.07.005","article-title":"Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives","volume":"134","author":"de Velde","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.3168\/jds.2024-25194_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","article-title":"Serum albumin: Relationship to inflammation and nutrition","volume":"17","author":"Don","year":"2004","journal-title":"Semin. Dial."},{"key":"10.3168\/jds.2024-25194_bib16","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib17","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib18","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib19","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib20","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib21","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib22","author":"EMA (European Medicines Agency)"},{"key":"10.3168\/jds.2024-25194_bib23","article-title":"PK\/PD analysis of marbofloxacin by Monte Carlo simulation against Mycoplasma agalactiae in plasma and milk of lactating goats after IV, SC, and SC-long acting formulations administration","volume":"11","author":"Fern\u00e1ndez-Var\u00f3n","year":"2021","journal-title":"Animals (Basel)"},{"key":"10.3168\/jds.2024-25194_bib24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0169-409X(03)00032-2","article-title":"Models and methods for predicting drug transfer into human milk","volume":"55","author":"Fleishaker","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.3168\/jds.2024-25194_bib25","author":"Food and Drug Administration"},{"key":"10.3168\/jds.2024-25194_bib26","series-title":"Antimicrobial Resistance in Bacteria from Livestock and Companion Animals","first-page":"425","article-title":"Antimicrobial resistance in Mycoplasma spp","author":"Gautier-Bouchardon","year":"2018"},{"key":"10.3168\/jds.2024-25194_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jcph.1650","article-title":"Nonparametric methods in population pharmacokinetics","volume":"62","author":"Goutelle","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1051\/vetres:2000100","article-title":"Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary mycoplasma species. International Research Programme on Comparative Mycoplasmology","volume":"31","author":"Hannan","year":"2000","journal-title":"Vet. Res."},{"key":"10.3168\/jds.2024-25194_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.rvsc.2006.10.001","article-title":"Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves","volume":"82","author":"Ismail","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"10.3168\/jds.2024-25194_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/13892002113149990002","article-title":"Systematic evaluation of dose accumulation studies in clinical pharmacokinetics","volume":"14","author":"Li","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.3168\/jds.2024-25194_bib31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jvp.12409","article-title":"Pharmacokinetics, milk penetration and PK\/PD analysis by Monte Carlo simulation of marbofloxacin, after intravenous and intramuscular administration to lactating goats","volume":"40","author":"Lorenzutti","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib32","article-title":"PK\/PD analysis by nonlinear mixed effects modeling of a marbofloxacin dose regimen for treatment of goat mastitis produced by coagulase-negative staphylococci","volume":"11","author":"Lorenzutti","year":"2021","journal-title":"Animals (Basel)"},{"key":"10.3168\/jds.2024-25194_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2015.01.046","article-title":"Using deconvolution to understand the mechanism for variable plasma concentration-time profiles after intramuscular injection","volume":"481","author":"Mahmood","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.3168\/jds.2024-25194_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.120.090704","article-title":"the impact of infection and inflammation on drug metabolism, active transport, and systemic drug concentrations in veterinary species","volume":"48","author":"Martinez","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.3168\/jds.2024-25194_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cvfa.2010.10.010","article-title":"Principles of mastitis treatment in sheep and goats","volume":"27","author":"Mavrogianni","year":"2011","journal-title":"Vet. Clin. North Am. Food Anim. Pract."},{"key":"10.3168\/jds.2024-25194_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0169-409X(03)00033-4","article-title":"Mammary physiology and milk secretion","volume":"55","author":"McManaman","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.3168\/jds.2024-25194_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044158","article-title":"Pharmacodynamics of antimicrobials against Mycoplasma mycoides mycoides small colony, the causative agent of contagious bovine pleuropneumonia","volume":"7","author":"Mitchell","year":"2012","journal-title":"PLoS One"},{"key":"10.3168\/jds.2024-25194_bib38","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1038\/psp.2012.4","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib39","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/psp.2013.14","article-title":"Basic concepts in population modeling, simulation, and model-based drug development\u2014Part 2, introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib40","first-page":"49","article-title":"Determination of renal handling of marbofloxacin in Lohi sheep (Ovis aries) following a single intravenous administration","volume":"18","author":"Munawar","year":"2017","journal-title":"Majallah-i Tahqiqat-i Dampizishki-i Iran"},{"key":"10.3168\/jds.2024-25194_bib41","article-title":"Antimicrobial and methicillin resistance pattern of potential mastitis-inducing Staphylococcus aureus and coagulase-negative staphylococci isolates from the mammary secretion of dairy goats","volume":"11","author":"Nelli","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.3168\/jds.2024-25194_bib42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vetmic.2013.12.021","article-title":"Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs","volume":"171","author":"Papich","year":"2014","journal-title":"Vet. Microbiol."},{"key":"10.3168\/jds.2024-25194_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/ajvr.23.07.0159","article-title":"Revision of fluoroquinolone breakpoints used for interpretation of antimicrobial susceptibility testing of canine bacterial isolates","volume":"84","author":"Papich","year":"2023","journal-title":"Am. J. Vet. Res."},{"key":"10.3168\/jds.2024-25194_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jvp.12418","article-title":"Pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin as a single injection for Pasteurellaceae respiratory infections in cattle using population pharmacokinetics and Monte Carlo simulations","volume":"41","author":"Paulin","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0442.1993.tb00602.x","article-title":"Pharmacokinetics of the gyrase inhibitor marbofloxacin: Influence of pregnancy and lactation in sows","volume":"40","author":"Petracca","year":"1993","journal-title":"J. Vet. Med. A Physiol. Pathol. Clin. Med."},{"key":"10.3168\/jds.2024-25194_bib46","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/jam.13083","article-title":"Diversity and variation in antimicrobial susceptibility patterns over time in Mycoplasma agalactiae isolates collected from sheep and goats in France","volume":"120","author":"Poumarat","year":"2016","journal-title":"J. Appl. Microbiol."},{"key":"10.3168\/jds.2024-25194_bib47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2885.2006.00744.x","article-title":"Interaction of enrofloxacin with breast cancer resistance protein (BCRP\/ABCG2): Influence of flavonoids and role in milk secretion in sheep","volume":"29","author":"Pulido","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib48","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1186\/2046-0481-62-S4-S40","article-title":"Treatment of mastitis during lactation","volume":"62","author":"Py\u00f6r\u00e4l\u00e4","year":"2009","journal-title":"Ir. Vet. J."},{"key":"10.3168\/jds.2024-25194_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2885.1996.tb00019.x","article-title":"Pharmacokinetic-pharmacodynamic model for spiramycin in staphylococcal mastitis","volume":"19","author":"Renard","year":"1996","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jvp.12278","article-title":"Mathematical modeling and simulation in animal health. Part I: moving beyond pharmacokinetics","volume":"39","author":"Riviere","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-011-1023-6","article-title":"Population pharmacokinetic modeling of tramadol and its O-desmethyl metabolite in plasma and breast milk","volume":"67","author":"Salman","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","article-title":"Importance of shrinkage in empirical Bayes estimates for diagnostics: Problems and solutions","volume":"11","author":"Savic","year":"2009","journal-title":"AAPS J."},{"key":"10.3168\/jds.2024-25194_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid0901.020277","article-title":"Maintaining fluoroquinolone class efficacy: Review of influencing factors","volume":"9","author":"Scheld","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.3168\/jds.2024-25194_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jvp.12991","article-title":"Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control","volume":"44","author":"Schenk","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3168\/jds.S0022-0302(04)73159-8","article-title":"Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains","volume":"87","author":"Schneider","year":"2004","journal-title":"J. Dairy Sci."},{"key":"10.3168\/jds.2024-25194_bib56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2125.1996.04231.x","article-title":"Estimating impossible curves using NONMEM","volume":"42","author":"Schoemaker","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib57","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/vr.103964","article-title":"Susceptibility and PK\/PD relationships of Staphylococcus aureus strains isolated from the milk of sheep and goats with clinical mastitis to five veterinary fluoroquinolones","volume":"180","author":"Serrano-Rodr\u00edguez","year":"2017","journal-title":"Vet. Rec."},{"key":"10.3168\/jds.2024-25194_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rvsc.2023.03.026","article-title":"Population pharmacokinetics and pharmacokinetic\/pharmacodynamic evaluation of marbofloxacin against coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats","volume":"159","author":"Serrano-Rodr\u00edguez","year":"2023","journal-title":"Res. Vet. Sci."},{"key":"10.3168\/jds.2024-25194_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1439-0442.1997.tb01137.x","article-title":"Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes","volume":"44","author":"Shem-Tov","year":"1997","journal-title":"J. Vet. Med. A Physiol. Pathol. Clin. Med."},{"key":"10.3168\/jds.2024-25194_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rvsc.2009.05.013","article-title":"PK\u2013PD integration and modeling of marbofloxacin in sheep","volume":"88","author":"Sidhu","year":"2010","journal-title":"Res. Vet. Sci."},{"issue":"Suppl. B","key":"10.3168\/jds.2024-25194_bib61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/43.suppl_2.61","article-title":"Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: Tissue distribution in male rats","volume":"43","author":"Siefert","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.3168\/jds.2024-25194_bib62","author":"Stankov"},{"key":"10.3168\/jds.2024-25194_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2885.2004.00605.x","article-title":"Plasma clearance","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2885.2004.00600.x","article-title":"Plasma terminal half-life","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02344","article-title":"En route towards European clinical breakpoints for veterinary antimicrobial susceptibility testing: A position paper explaining the VetCAST approach","volume":"8","author":"Toutain","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.3168\/jds.2024-25194_bib66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/psp4.12929","article-title":"Biased computation of probability of target attainment for antimicrobial drugs","volume":"12","author":"Toutain","year":"2023","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jvp.12917","article-title":"The pharmacokinetic\/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: Recent advances and critical appraisal","volume":"44","author":"Toutain","year":"2021","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.01310","article-title":"VetCAST method for determination of the pharmacokinetic-pharmacodynamic cut-off values of a long acting formulation of florfenicol to support clinical breakpoints for florfenicol antimicrobial susceptibility testing in cattle","volume":"10","author":"Toutain","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.3168\/jds.2024-25194_bib69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1469-0691.2006.01377.x","article-title":"Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values","volume":"12","author":"Turnidge","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.3168\/jds.2024-25194_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.770202","article-title":"Population pharmacokinetics of intravenous amoxicillin combined with clavulanic acid in healthy and critically ill dogs","volume":"8","author":"Vegas C\u00f3mitre","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.3168\/jds.2024-25194_bib71","author":"VICH (International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products)"},{"key":"10.3168\/jds.2024-25194_bib72","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jvp.12802","article-title":"Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs","volume":"42","author":"Wang","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib73","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/bcp.14278","article-title":"A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk. Multicenter Study","volume":"86","author":"Weisskopf","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.3168\/jds.2024-25194_bib74","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jvp.12812","article-title":"Physiologically based modelling of the pharmacokinetics of three beta-lactam antibiotics after intra-mammary administration in dairy cows","volume":"42","author":"Woodward","year":"2019","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.3168\/jds.2024-25194_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jvp.13012","article-title":"PK\/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli.","volume":"45","author":"Xiao","year":"2022","journal-title":"J. Vet. Pharmacol. Ther."}],"container-title":["Journal of Dairy Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022030225001420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022030225001420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T19:32:12Z","timestamp":1762198332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022030225001420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022030225001420"],"URL":"https:\/\/doi.org\/10.3168\/jds.2024-25194","relation":{},"ISSN":["0022-0302"],"issn-type":[{"value":"0022-0302","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic\/pharmacodynamic modeling in plasma and milk and Monte Carlo simulations of marbofloxacin against Staphylococcus aureus and Mycoplasma agalactiae in lactating sheep","name":"articletitle","label":"Article Title"},{"value":"Journal of Dairy Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3168\/jds.2024-25194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025","name":"copyright","label":"Copyright"}]}}